Drug Type Small molecule drug |
Synonyms S 16474, S-16474 |
Target |
Action antagonists |
Mechanism NK1R antagonists(Neurokinin 1 receptor antagonists), NK2R antagonists(Neurokinin 2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H48N6NaO8 |
InChIKeyGWRYRWLLVKEEKO-FFOXNNBDSA-N |
CAS Registry149250-10-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory tract inflammation | Preclinical | France | 29 Dec 1995 | |
Asthma | Discovery | France | - |